Skip to main content

Quality and Safety

By Jeff Lagasse | 04:10 pm | May 19, 2020
Reports of severe illness among children are mounting, requiring more urgent research into susceptibility and possible treatments.
By Susan Morse | 08:07 pm | May 18, 2020
CMS Administrator Seema Verma gave no timetable, but the agency said reopening would only happen in phase three.
By HIMSS TV | 03:34 pm | May 18, 2020
Remote monitoring tech can help reach patients at home and reduce contact with COVID-19-positive patients, says Kuldeep Singh Rajput, CEO and founder of Biofourmis.
By Susan Morse | 06:57 pm | May 15, 2020
The public and private partnership includes the Department of Defense to enable faster distribution.
By Susan Morse | 04:18 pm | May 15, 2020
UnitedHealth Group will maintain control over the protected health data and will manage opt-in and consent requirements.
By Jeff Lagasse | 03:54 pm | May 15, 2020
Hydroxychloroquine can reduce inflammation, pain and swelling, but mild to moderate COVID patients showed more adverse events when treated with it.
By Susan Morse | 10:21 am | May 14, 2020
America's Health Insurance Plans is also promoting the continued widespread adoption and use of telemedicine.
By Susan Morse | 08:44 am | May 14, 2020
Phases 2 and 3 of vaccine clinical trials are expected by early summer and their success will be known by early winter, Fauci says.
By HIMSS TV | 07:58 am | May 14, 2020
Pharmacogenomics is a good entry point for providers in precision medicine, identifying the right medicine for better outcomes and patient satisfaction, according to Joel Diamond, MD, CMO of 2bPrecise.
By Jeff Lagasse | 04:21 pm | May 12, 2020
In addition to an expanded ED, the hospital knew it had to improve interstaff communications to bolster patient care.